Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis
Authors:
- Yves AllenbachYAYves Allenbach
- Olivier BenvenisteOBOlivier Benveniste
- Valérie DecostreVDValérie Decostre
- Aurélie CanalACAurélie Canal
- Bruno EymardBEBruno Eymard
- Serge HersonSHSerge Herson
- Coralie Bloch-QueyratCBCoralie Bloch-Queyrat
- Jean-Yves HogrelJHJean-Yves Hogrel
- 1 November 2012
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 22 (11) , 980-986
Abstract
No abstract availableKeywords
Funding Information
- Société Française de Médecine Interne (SNFMI)
- Association Française contre les Myopathies (AFM)
This publication has 17 references indexed in Scilit:
- Long-term observational study of sporadic inclusion body myositisBrain, 2011
- Predicting maximal grip strength using hand circumferenceManual Therapy, 2010
- Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositisBrain, 2009
- Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brainsActa Neuropathologica, 2008
- Inclusion body myositis functional rating scale: A reliable and valid measure of disease severityMuscle & Nerve, 2008
- Inflammatory, immune, and viral aspects of inclusion-body myositisNeurology, 2006
- A prospective natural history study of inclusion body myositisNeurology, 2001
- Inclusion body myositis and myopathiesAnnals of Neurology, 1995
- Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 casesActa Neurologica Scandinavica, 1994
- The Rivermead Mobility Index: A further development of the Rivermead Motor AssessmentInternational Disability Studies, 1991